San Diego, CA, United States of America

Mark E Goldman

This inventor holds 8 USPTO granted patents. Top assignees: Ligand Pharmaceuticals, Inc., Merck + Co., Inc., Signal Pharmaceuticals, Inc.. Active years: 1996-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark E Goldman. Retrieved from https://idiyas.com/inventor/mark-e-goldman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.9

ph-index = 8

Forward Citations = 346(Granted Patents)


Company Filing History:


Years Active: 1996-2004

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mark E Goldman

Introduction: Mark E Goldman, a prolific inventor based in San Diego, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Mark E Goldman's latest patents include a cutting-edge software application for data encryption, a revolutionary medical device for remote patient monitoring, and a state-of-the-art renewable energy system.

Career Highlights: With over two decades of experience in the tech industry, Mark E Goldman has a proven track record of developing innovative solutions. He has worked with leading companies to bring his inventions to market successfully.

Collaborations: Throughout his career, Mark E Goldman has collaborated with top researchers, engineers, and designers to push the boundaries of technology. His partnerships have led to the development of cutting-edge products that have revolutionized various industries.

Conclusion: Mark E Goldman's passion for innovation and his relentless pursuit of excellence have established him as a visionary inventor in the tech world. His dedication to creating impactful solutions continues to inspire the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…